101 related articles for article (PubMed ID: 21692036)
1. Parafibromin expression in lung normal tissue and carcinoma: its comparison with clinicopathological parameters of carcinoma.
Xia P; Wang W; Xu XY; Wang JP; Takano Y; Zheng HC
Histol Histopathol; 2011 Aug; 26(8):1039-47. PubMed ID: 21692036
[TBL] [Abstract][Full Text] [Related]
2. Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Virchows Arch; 2008 Feb; 452(2):147-55. PubMed ID: 18080135
[TBL] [Abstract][Full Text] [Related]
3. Parafibromin expression is an independent prognostic factor for colorectal carcinomas.
Zheng HC; Wei ZL; Xu XY; Nie XC; Yang X; Takahashi H; Takano Y
Hum Pathol; 2011 Aug; 42(8):1089-102. PubMed ID: 21315421
[TBL] [Abstract][Full Text] [Related]
4. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
5. Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.
Lin YL; Chen HL; Cheng SB; Yeh DC; Huang CC; P'eng FK; Tsai TC; Wu CC; Chen CM
Int J Clin Exp Pathol; 2015; 8(11):14257-69. PubMed ID: 26823742
[TBL] [Abstract][Full Text] [Related]
6. Effects of parafibromin expression on the phenotypes and relevant mechanisms in the DLD-1 colon carcinoma cell line.
Zhao S; Sun HZ; Zhu ST; Lu H; Niu ZF; Guo WF; Takano Y; Zheng HC
Asian Pac J Cancer Prev; 2013; 14(7):4249-54. PubMed ID: 23991985
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological and prognostic significances of CDC73 expression in breast cancer: A pathological and bioinformatics analysis.
E Y; Xue H; Zhang CY; Zhao MZ; Zheng HC
Histol Histopathol; 2023 Apr; 38(4):453-465. PubMed ID: 36255176
[TBL] [Abstract][Full Text] [Related]
8. The in vitro and vivo effects of nuclear and cytosolic parafibromin expression on the aggressive phenotypes of colorectal cancer cells: a search of potential gene therapy target.
Zheng HC; Liu JJ; Li J; Wu JC; Yang L; Zhao GF; Zhao X; Jiang HM; Huang KQ; Li ZJ
Oncotarget; 2017 Apr; 8(14):23603-23612. PubMed ID: 28223542
[TBL] [Abstract][Full Text] [Related]
9. The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy.
Shen DF; Liu X; Yang XF; Fang L; Gao Y; Zhao S; Wu JC; Shi S; Li JJ; Zhao XX; Gou WF; Zheng HC
Tumour Biol; 2016 Mar; 37(3):2909-24. PubMed ID: 26409451
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma.
Howell VM; Gill A; Clarkson A; Nelson AE; Dunne R; Delbridge LW; Robinson BG; Teh BT; Gimm O; Marsh DJ
J Clin Endocrinol Metab; 2009 Feb; 94(2):434-41. PubMed ID: 19017757
[TBL] [Abstract][Full Text] [Related]
11. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma.
Kim HK; Oh YL; Kim SH; Lee DY; Kang HC; Lee JI; Jang HW; Hur KY; Kim JH; Min YK; Chung JH; Kim SW
Head Neck; 2012 Feb; 34(2):201-6. PubMed ID: 21717519
[TBL] [Abstract][Full Text] [Related]
12. Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas.
Zheng HC; Xu XY; Xing YN; Wei ZL; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 May; 41(5):724-36. PubMed ID: 20096920
[TBL] [Abstract][Full Text] [Related]
13. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y
Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444
[TBL] [Abstract][Full Text] [Related]
14. Parafibromin expression in breast cancer: a novel marker for prognostication?
Selvarajan S; Sii LH; Lee A; Yip G; Bay BH; Tan MH; Teh BT; Tan PH
J Clin Pathol; 2008 Jan; 61(1):64-7. PubMed ID: 17468290
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathological significance of REIC expression in colorectal carcinomas.
Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
[TBL] [Abstract][Full Text] [Related]
17. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
[TBL] [Abstract][Full Text] [Related]
18. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of TESTIN in primary gastric cancer].
Huang W; Weng DS; Pan ZZ; Pan K; Ding PR; Zhou J; Wang H; Zhang HK; Li JJ; Xia JC
Ai Zheng; 2008 Sep; 27(9):984-8. PubMed ID: 18799041
[TBL] [Abstract][Full Text] [Related]
20. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]